12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks showed significant movement. Tevogen Bio Holdings led the gainers with a 55.4% increase, while Applied DNA Sciences experienced the largest drop among the losers at 13.1%. Earnings reports were a common factor influencing stock movements, with companies like Dynatronics, Tarsus Pharmaceuticals, Fulcrum Therapeutics, and Fortrea Holdings recently releasing their financial results.
May 13, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied DNA Sciences experienced a 13.1% decline in its stock price to $3.0, following the release of its Q2 earnings report.
The negative reaction to APDN's Q2 earnings report suggests investor disappointment, likely leading to short-term price decline.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Fortrea Holdings experienced a 9.09% decrease to $30.03, with a market cap of $2.6 billion, following its Q1 earnings release today.
FTRE's stock price decline post-Q1 earnings suggests the results may not have met investor expectations, likely affecting its short-term price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Dynatronics reported a 21.69% increase to $0.57, following its Q3 earnings release two days ago, with a market cap of $2.8 million.
The positive response to DYNT's Q3 earnings indicates favorable investor sentiment, potentially boosting its stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Fulcrum Therapeutics rose 13.78% to $8.5, with a market value of $528.3 million, after releasing its Q1 earnings today.
The increase in FULC's stock price post-Q1 earnings indicates positive investor reception, suggesting potential short-term growth.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Tarsus Pharmaceuticals saw an 18.08% increase to $43.69, with its market value at $1.6 billion, following its Q1 earnings report.
TARS's stock price increase post-Q1 earnings suggests strong financial performance, likely leading to continued investor interest.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Tevogen Bio Holdings saw a significant pre-market increase of 55.4%, with its market value reaching $251.8 million.
The substantial pre-market increase in TVGN's stock price could attract more investors, potentially leading to short-term price appreciation.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90